- Home
- RPTX vs SER Comparison
RPTX vs SER Comparison
Compare RPTX & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- SER
- Stock Information
- Founded
- RPTX 2016
- SER 2017
- Country
- RPTX Canada
- SER United States
- Employees
- RPTX N/A
- SER N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- RPTX Health Care
- SER Health Care
- Exchange
- RPTX Nasdaq
- SER Nasdaq
- Market Cap
- RPTX 53.2M
- SER 47.5M
- IPO Year
- RPTX 2020
- SER 2018
- Fundamental
- Price
- RPTX $1.12
- SER $4.11
- Analyst Decision
- RPTX Strong Buy
- SER Strong Buy
- Analyst Count
- RPTX 3
- SER 1
- Target Price
- RPTX $4.50
- SER $11.00
- AVG Volume (30 Days)
- RPTX 185.4K
- SER 10.0K
- Earning Date
- RPTX 03-03-2025
- SER 11-12-2024
- Dividend Yield
- RPTX N/A
- SER N/A
- EPS Growth
- RPTX N/A
- SER N/A
- EPS
- RPTX N/A
- SER N/A
- Revenue
- RPTX $53,477,000.00
- SER $3,157,500.00
- Revenue This Year
- RPTX N/A
- SER N/A
- Revenue Next Year
- RPTX $7.11
- SER N/A
- P/E Ratio
- RPTX N/A
- SER N/A
- Revenue Growth
- RPTX 4.58
- SER 2454.55
- 52 Week Low
- RPTX $1.06
- SER $3.81
- 52 Week High
- RPTX $5.66
- SER $22.32
- Technical
- Relative Strength Index (RSI)
- RPTX 36.62
- SER 32.61
- Support Level
- RPTX $1.12
- SER $4.66
- Resistance Level
- RPTX $1.25
- SER $4.87
- Average True Range (ATR)
- RPTX 0.09
- SER 0.20
- MACD
- RPTX -0.00
- SER -0.05
- Stochastic Oscillator
- RPTX 22.64
- SER 1.14
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.